Company intelligence / Profile preview

Halden Pharma

Halden, Østfold, Norwayhalden-pharma.com ↗

Ownership: Private
Employees: ~197
Development stage: Other

Overview

Halden Pharma is one of the largest and most advanced sterile pharmaceutical production facilities in Northern Europe. It specializes in contract development and manufacturing of sterile and non-sterile liquid pharmaceuticals using state-of-the-art technologies such as blow-fill-seal. The site holds major international certifications including EU-GMP and US-FDA approval. It was formerly owned by Fresenius Kabi before being acquired by Prange Group in late 2023/early 2024. The company serves global pharma customers with commercial-scale manufacturing capabilities.

Modalities: Sterile liquidsNon-sterile liquids & gelsIV bagsampoulesvialspre-filled syringesophthalmics
Industry: Contract Manufacturing Organization

Partnerships

Fresenius Kabi (client)Adragos group

Beyond the preview

Go deeper on Halden Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Halden Pharma.

Explore the full profile